Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-20 | G1 Therapeutics, Inc. | Avagliano Mark
(Chief Business Officer) |
A | Common Stock | A | 100000 | $0.00 - $0.00 | $0 |
| 2024-03-20 | G1 Therapeutics, Inc. | Umstead John W. V
(Chief Financial Officer) |
A | Common Stock | A | 37500 | $0.00 - $0.00 | $0 |
| 2024-02-12 | G1 Therapeutics, Inc. | Malik Rajesh
(Chief Medical Officer) |
S | Common Stock | D | 28600 | $4.62 - $4.62 | $132,143 |
| 2024-02-12 | G1 Therapeutics, Inc. | Malik Rajesh
(Chief Medical Officer) |
M | Common Stock | A | 28600 | $0.30 - $0.30 | $8,580 |
| 2024-01-03 | G1 Therapeutics, Inc. | Umstead John W. V
(Chief Financial Officer) |
S | Common Stock | D | 743 | $2.94 - $3.12 | $2,297 |
| 2024-01-03 | G1 Therapeutics, Inc. | Umstead John W. V
(Chief Financial Officer) |
A | Common Stock | A | 37300 | $0.00 - $0.00 | $0 |
| 2024-01-03 | G1 Therapeutics, Inc. | Thomas Monica R.
(General Counsel) |
A | Common Stock | A | 27975 | $0.00 - $0.00 | $0 |
| 2024-01-03 | G1 Therapeutics, Inc. | Malik Rajesh
(Chief Medical Officer) |
S | Common Stock | D | 3740 | $2.94 - $3.12 | $11,536 |
| 2024-01-03 | G1 Therapeutics, Inc. | Malik Rajesh
(Chief Medical Officer) |
A | Common Stock | A | 37300 | $0.00 - $0.00 | $0 |
| 2024-01-03 | G1 Therapeutics, Inc. | Perry Andrew
(Chief Commercial Officer) |
S | Common Stock | D | 2413 | $3.12 - $3.12 | $7,525 |
| 2024-01-03 | G1 Therapeutics, Inc. | Perry Andrew
(Chief Commercial Officer) |
A | Common Stock | A | 33570 | $0.00 - $0.00 | $0 |
| 2024-01-03 | G1 Therapeutics, Inc. | Bailey John E. (J...
(President and CEO) |
S | Common Stock | D | 11686 | $3.12 - $3.12 | $36,447 |
| 2024-01-03 | G1 Therapeutics, Inc. | Bailey John E. (J...
(President and CEO) |
A | Common Stock | A | 100700 | $0.00 - $0.00 | $0 |
| 2024-01-03 | G1 Therapeutics, Inc. | Avagliano Mark
(Chief Business Officer) |
S | Common Stock | D | 4081 | $2.94 - $3.12 | $12,600 |
| 2024-01-03 | G1 Therapeutics, Inc. | Avagliano Mark
(Chief Business Officer) |
A | Common Stock | A | 44760 | $0.00 - $0.00 | $0 |
| 2024-01-03 | G1 Therapeutics, Inc. | MURDOCK TERRY L
(Chief Operating Officer) |
S | Common Stock | D | 3740 | $2.94 - $3.12 | $11,536 |
| 2024-01-03 | G1 Therapeutics, Inc. | MURDOCK TERRY L
(Chief Operating Officer) |
A | Common Stock | A | 37300 | $0.00 - $0.00 | $0 |
| 2024-01-02 | G1 Therapeutics, Inc. | Bailey John E. (J...
(President and CEO) |
S | Common Stock | D | 32983 | $3.27 - $3.27 | $108,006 |
| 2023-12-11 | G1 Therapeutics, Inc. | Malik Rajesh
(Chief Medical Officer) |
S | Common Stock | D | 33839 | $3.06 - $4.02 | $115,521 |
| 2023-12-11 | G1 Therapeutics, Inc. | Malik Rajesh
(Chief Medical Officer) |
M | Common Stock | A | 33839 | $0.30 - $0.39 | $12,081 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |